SCHEMBL16601603

SCHEMBL16601603

CCN1C(=O)C(C)(C)Sc2cc(C)ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
ALDH1A1 P00352 10/20 0.38
EPHX2 P34913 1/20 0.36
MAPT P10636 9/20 0.36
KMT2A Q03164 7/20 0.36
MAPK1 P28482 6/20 0.36
MEN1 O00255 6/20 0.36
SMN1; SMN2 Q16637 6/20 0.36
KDM4E B2RXH2 5/20 0.36
POLB P06746 5/20 0.36
LMNA P02545 4/20 0.36
NPC1 O15118 3/20 0.36
HSP90AA1 P07900 3/20 0.36
HTT P42858 3/20 0.36
RAB9A P51151 3/20 0.36
RECQL P46063 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PKM P14618 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13962150 0.84 CASP3 (0.33) CYP2C9CYP2C19ALDH1A1MAPTKMT2A
SCHEMBL13340953 0.81 OPRK1 (0.34) CYP2C9CYP2C19ALDH1A1MAPTKMT2A
SCHEMBL9269968 0.80 PKM (0.42) ALDH1A1EPHX2MAPTKMT2AMEN1
SCHEMBL13212473 0.73 MAPT (0.48) ALDH1A1MAPTKMT2AMAPK1MEN1
SCHEMBL5543415 0.73 CYP2C9 (0.49) CYP2C9CYP2C19ALDH1A1MAPTKMT2A
SCHEMBL16601582 0.70 ALDH1A1 (0.38) CYP2C9CYP2C19ALDH1A1MAPTKMT2A
SCHEMBL13367651 0.70 RXRA (0.43) CYP2C9CYP2C19ALDH1A1MAPTKMT2A
SCHEMBL13434186 0.68 TSHR (0.36) CYP2C9ALDH1A1MAPTKMT2AMAPK1
SCHEMBL628451 0.67 KDM1A (0.49) CYP2C19ALDH1A1MAPTKMT2AMAPK1
SCHEMBL16601592 0.66 KMT2A (0.38) CYP2C9CYP2C19ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8993585-B2 Cyclic amine substituted pyrimidinediamines as PKC inhibitors RIGEL PHARMACEUTICALS, INC. (US) 2015-03-31 US disclosed